Aridis Pharmaceuticals Inc. (ARDS) Financials
ARDS Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 6.5 million | 30.1 million |
2023-06-30 | 6.5 million | 21.4 million |
2023-03-31 | 14.7 million | 38.9 million |
2022-12-31 | 14.7 million | 38.9 million |
ARDS Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -983000 | 200000 |
2023-06-30 | -4.3 million | 210000 |
2023-03-31 | -8.6 million | 318000 |
2022-12-31 | -8.6 million | 318000 |
ARDS Net Income
No data available :(
ARDS Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 35000 | - | 1.4 million |
2023-06-30 | 19000 | - | 1.6 million |
2023-03-31 | 4.9 million | - | 1.7 million |
2022-12-31 | - | - | 1.8 million |
ARDS Shares Outstanding
ARDS Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 175000 | 1.1 million | - |
2023-06-30 | - | 4.7 million | 1.3 million | - |
2023-03-31 | 49000 | 7.0 million | 1.6 million | - |
2022-12-31 | 49000 | 7.0 million | 1.6 million | - |
ARDS Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 417000 | - |
2023-06-30 | 19.6 million | - |
2023-03-31 | - | - |
2022-12-31 | - | - |
ARDS
Price: $0.06
52 week price:
Earnings Per Share: -0.16 USD
P/E Ratio: -0.45
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Volume: 543871
Market Capitalization: 3.2 million